文献速递膀胱癌与上尿路尿路上皮癌

社会经济剥夺对上尿路尿路上皮癌分期、死亡与复发的影响

Effects of Socioeconomic Deprivation on UTUC Staging, Mortality, and Recurrence.
PubMed 文献 · Urology · 2024-12-19

单中心研究纳入2010年2月至2021年8月接受根治性肾输尿管切除术或输尿管切除术的上尿路尿路上皮癌患者,按区域剥夺指数第50百分位分为优势组215例与劣势组217例。优势组新辅助化疗使用率高于劣势组(20% vs 13%,P=.035),但最优势与最劣势四分位组间无显著差异(18% vs 14%,P=.45);两组切缘阳性率、肿瘤特征、中位无复发生存期和总生存期均无显著差异。

要点

  • 优势组新辅助化疗使用率高于劣势组(20% vs 13%,P=.035)。
  • 最优势与最劣势四分位组新辅助化疗使用率无显著差异(18% vs 14%,P=.45)。
  • 两组切缘阳性率、肿瘤特征、无复发生存期和总生存期均无显著差异。

核心结论

  • 在该区域数据中,社会经济地位劣势组与优势组的上尿路尿路上皮癌分期、复发和死亡无显著差异,可能反映医疗可及性和循证管理方面的改善。

研究设计与样本

  • 单中心研究,纳入2010年2月至2021年8月接受根治性肾输尿管切除术或输尿管切除术的上尿路尿路上皮癌患者,按区域剥夺指数第50百分位分为优势组215例和劣势组217例。

主要发现

  • 优势组新辅助化疗使用率高于劣势组(20% vs 13%,P=.035)。
  • 最优势与最劣势四分位组新辅助化疗使用率无显著差异(18% vs 14%,P=.45)。
  • 两组切缘阳性率无显著差异(11% vs 13%,P=.53)。
  • 两组中位肿瘤大小(P=.15)、病理肿瘤分期(P=.81)和病理淋巴结分期(P=.28)相似。
  • 两组中位无复发生存期和总生存期均无差异。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To determine whether the area deprivation index (ADI), a surrogate for socioeconomic status (SES) associated with patient residence, affected UTUC staging, recurrence rates, and mortality. METHODS: Patients undergoing radical nephroureterectomy or ureterectomy for UTUC at a single institution between February 2010 and August 2021 were classified by ADI. A 50th percentile cut-off of ADI classified patients as "advantaged" or "disadvantaged. Tumor characteristics, staging, and use of neoadjuvant chemotherapy were compared between groups. Recurrence-free (RFS) and overall survival (OS) were compared among groups using Mantel-Cox log-rank testing. RESULTS: In this cohort, 215 patients had advantaged SES, and 217 had disadvantaged SES. Neoadjuvant chemotherapy was utilized more frequently among advantaged versus disadvantaged patients (20% vs 13%, P=.035), though this difference was not significant when comparing the most advantaged and least advantaged quartiles (18% vs 14%, P=.45). No significant difference was observed in positive resection margins between groups (11% vs 13%, P=.53). Tumor characteristics, including median tumor size (P=.15), pathologic tumor stage (P=.81), and pathologic lymph node stage (P=.28), were also similar. There were no differences in median RFS or OS between SES groups. CONCLUSION: This regional data, considering previous studies suggesting worse outcomes with increased urothelial carcinoma incidence and mortality in those with a lower socioeconomic status, may reflect efforts to improve healthcare access and adhere to evidence-based management patterns.

来源:Urology,查看原文。版权归原作者所有。

引用

  1. Wahlstedt ER, Varadhan AK, Wahlstedt JC, et al. Effects of Socioeconomic Deprivation on UTUC Staging, Mortality, and Recurrence. Urology. 2024. PMID: 39674377. doi:10.1016/j.urology.2024.12.008

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。